American Herbal Products Association (AHPA) > About Us > Committees > Government Relations Committee

Government Relations Committee

Chairperson: Staci Eisner (Cortex Scientific)
Staff Contact: Michael McGuffin

Committee Purpose: To monitor legislative and regulatory issues and agencies for the purpose of developing industry positions that conform to AHPA's mission.

AHPA Members, if you would like to join this committee, please email the staff contact.

 

Committee Meeting Minutes

September 28, 2017 Meeting Minutes

Meeting of the Government Relations Committee

AHPA Members log in to download the meeting minutes.

March 10, 2017 Meeting Minutes

Meeting of the Government Relations Committee

AHPA Members log in to download the meeting minutes.

October 7, 2016 Meeting Minutes

AHPA Government Relations Committee meeting minutes

AHPA Members log in to download the meeting minutes.
RSS
12

Committee-Related News

AHPA meetings and events at Natural Products Expo West

AHPA meetings and events at Natural Products Expo West

AHPA Annual Member meeting, reception, awards, committee meetings and more!

March 5-8, 2019 -- Anaheim Convention Center, California

FDA Announces New Attention to Dietary Supplement Regulations

Prominent focus on public health and safety, mandatory product listing and new dietary ingredients

AHPA submits comments on use of dairy names for plant-based product labels

On January 28, 2019, AHPA submitted comments to the Food and Drug Administration (FDA) urging the agency to ensure that any rule or guidance that the agency may adopt on the use of dairy names (e.g., “milk,” “cream,” “butter,” etc.) on the labels of plant-based products expressly does not apply to any such product that is not generally used as a substitute for or marketed to resemble a dairy product.
AHPA Member Reception at ExpoWest

AHPA Member Reception at ExpoWest

Our way of thanking members for all their invaluable contributions

AHPA Members and their friends are invited to the AHPA Member Reception at Natural Products Expo West. No registration required. This is AHPA's way of thanking you for all you do to promote the responsible commerce of herbal products.

Revised Hemp-CBD Status Report

How hemp and CBD companies are impacted by passage of the Farm Bill

Congress passed a Farm Bill in 2018 that included historic provisions to legalize hemp, the low THC cultivars of the Cannabis sativa L. species. This landmark legislation changes how hemp and hemp-derived products like cannabidiol (CBD) are regulated in the U.S. To help the herbal products industry understand the new regulatory landscape, AHPA has expanded this Status Report and to answer industry questions about the new legal landscape.

USDA’s final rule for GMO labeling ignores recommendations of consumers and AHPA

Final rule hinders consumer access to information on genetically modified foods

The U.S. Department of Agriculture (USDA) Agricultural Marketing Service (AMS) issued a final rule on December 20 that establishes the new national mandatory bioengineered (BE) food disclosure standard. The final rule does not incorporate significant revisions recommended by AHPA and consumer groups that were aimed at ensuring U.S. consumers can discern if their food includes genetically modified organisms (GMOs) or ingredients derived from GMOs.

Nutritional supplements access preserved in Arizona

AHPA and NPA protect proper rules for safe, legal, natural products

A proposal that would have drastically limited access to safe, legal and popular products for Arizonans was changed recently thanks to the Natural Products Association (NPA) and the American Herbal Products Association (AHPA), who worked with the Arizona Board of Pharmacy and other state policymakers on the issue.

Dietary Supplements Regulatory Summit

Hosted by AHPA, CHPA, CRN, NPA and UNPA

This one-day regulatory summit will feature updates and insights from FDA and industry regulatory experts, and will focus on the key regulatory compliance issues facing the dietary supplements industry.
FDA Update by ODSP Director Steven Tave Presented at 7th Annual AHPA Botanical Congress

FDA Update by ODSP Director Steven Tave Presented at 7th Annual AHPA Botanical Congress

Tave outlines collaborations between FDA and supplement industry to ensure consumer safety

The American Herbal Products Association’s (AHPA’s) 7th Annual Botanical Congress featured a Food and Drug Administration (FDA) update by Steven Tave, FDA’s Director of the Office of Dietary Supplement Programs (ODSP), who highlighted recent collaborations between the responsible supplement industry and FDA toward the shared goal of a well-regulated dietary supplement market.

Arizona Board of Pharmacy reportedly considers most dietary supplements to be nonprescription drugs

Board is pushing supplement companies that sell in the state to register as "wholesaler of nonprescription drugs"

The Arizona State Board of Pharmacy recently began interpreting its authority in a manner that implies that virtually every company that manufacturers or sells dietary supplements in the state will need to register as a nonprescription drug facility. If the board is successful and persistent in this approach, it could significantly disrupt dietary supplement business in the state.
RSS
12345